发明名称 Pharmaceutical preparation for determination of a minimum undesired effect of apomorphine
摘要 <p>Symptoms of Parkinson's disease and psychogenic male erectile dysfunction (MED) can be ameliorated through the use of apomorphine. The adverse side effects of apomorphine administration, such as nausea, vomiting, yawning, and cardiovascular effects, can be significantly reduced by a dose escalating method of acclimatization. An initial dose of apomorphine is administered to the patient, and subsequently increased over a period of time until a final apomorphine dose in excess of a desired therapeutic dose has been received by the patient. Thereafter a therapeutic dose of apomorphine, less than the final apomorphine dose, is administered to the patient with attendant reduced side effects.</p>
申请公布号 CZ20010610(A3) 申请公布日期 2002.03.13
申请号 CZ20010000610 申请日期 1999.07.01
申请人 PENTECH PHARMACEUTICALS, INC. 发明人 EL-RASHIDY RAGAB;RONSEN BRUCE
分类号 A61K31/435;A61K31/473;A61P15/10;A61P25/16;A61P25/22;(IPC1-7):A61K31/445;C07D211/70;A61P15/00 主分类号 A61K31/435
代理机构 代理人
主权项
地址